Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 1.000 | |
| 5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.599 | |
| 2wou | ZZF | TGF-beta receptor type-1 | 2.7.11.30 | 0.575 | |
| 1vjy | 460 | TGF-beta receptor type-1 | 2.7.11.30 | 0.547 | |
| 3gxl | QIG | TGF-beta receptor type-1 | 2.7.11.30 | 0.534 | |
| 3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.534 | |
| 3hmm | 855 | TGF-beta receptor type-1 | 2.7.11.30 | 0.529 | |
| 1rw8 | 580 | TGF-beta receptor type-1 | 2.7.11.30 | 0.526 | |
| 2iw8 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.515 | |
| 1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.511 | |
| 1byg | STU | Tyrosine-protein kinase CSK | / | 0.504 | |
| 1h1r | 6CP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.504 | |
| 4dym | IYZ | Activin receptor type-1 | 2.7.11.30 | 0.503 | |
| 4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.497 | |
| 3uzp | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.495 | |
| 4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.493 | |
| 1h1s | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.491 | |
| 4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.489 | |
| 3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.487 | |
| 4erw | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.487 | |
| 3s2p | PMU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.486 | |
| 4qmp | DKI | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.486 | |
| 3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.483 | |
| 4c02 | TAK | Activin receptor type-1 | 2.7.11.30 | 0.483 | |
| 4eor | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.483 | |
| 2iw9 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.481 | |
| 3uyt | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.481 | |
| 5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.481 | |
| 3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.480 | |
| 2c0o | L2G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.479 | |
| 3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.479 | |
| 3oom | 507 | Activin receptor type-1 | 2.7.11.30 | 0.478 | |
| 4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.478 | |
| 1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.477 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.477 | |
| 3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.477 | |
| 1py5 | PY1 | TGF-beta receptor type-1 | 2.7.11.30 | 0.475 | |
| 5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.475 | |
| 1v0p | PVB | Cell division control protein 2 homolog | 2.7.11.22 | 0.474 | |
| 4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.474 | |
| 2yn8 | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.473 | |
| 3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.473 | |
| 1u54 | ACP | Activated CDC42 kinase 1 | / | 0.472 | |
| 2iw6 | QQ2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.472 | |
| 4bgg | 844 | Activin receptor type-1 | 2.7.11.30 | 0.472 | |
| 2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.471 | |
| 3ddp | RC8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.471 | |
| 1oiu | N76 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.470 | |
| 3say | OFT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.470 | |
| 3vs0 | VS0 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.470 | |
| 4fv9 | E71 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.470 | |
| 4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.470 | |
| 1oi9 | N20 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.469 | |
| 3w32 | W32 | Epidermal growth factor receptor | 2.7.10.1 | 0.466 | |
| 1jpa | ANP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.465 | |
| 4eon | 1RO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.465 | |
| 4hnf | 16W | Casein kinase I isoform delta | 2.7.11.1 | 0.465 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.465 | |
| 1di8 | DTQ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.464 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.464 | |
| 4bcn | T9N | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
| 1ogu | ST8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
| 1g5s | I17 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.462 | |
| 3poz | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.462 | |
| 4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.462 | |
| 4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.461 | |
| 5e8y | STU | TGF-beta receptor type-2 | 2.7.11.30 | 0.460 | |
| 1ke7 | LS3 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.459 | |
| 2nry | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.459 | |
| 3ddq | RRC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.459 | |
| 4c61 | LMM | Tyrosine-protein kinase JAK2 | / | 0.459 | |
| 2vwz | 7X6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.458 | |
| 2vx1 | 7X8 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.458 | |
| 4bkz | 1WS | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.458 | |
| 4fuy | EK2 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.458 | |
| 4gfo | 0X2 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.458 | |
| 4qmt | H1N | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.458 | |
| 4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.458 | |
| 1unl | RRC | Cyclin-dependent-like kinase 5 | 2.7.11.1 | 0.457 | |
| 1vyw | 292 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
| 2i0y | 5CN | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.457 | |
| 2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.457 | |
| 3ggf | GVD | Serine/threonine-protein kinase 26 | / | 0.457 | |
| 3r1s | X73 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
| 4gih | 0X5 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.457 | |
| 2hy8 | 1ST | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.456 | |
| 3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.456 | |
| 3zep | 1NX | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.456 | |
| 2w05 | FRT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
| 3r04 | UNQ | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.455 | |
| 4bcp | T3C | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
| 1h0w | 207 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
| 1kbq | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.454 | |
| 2p33 | J07 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.454 | |
| 3ocg | OCG | Mitogen-activated protein kinase 14 | / | 0.454 | |
| 3qu0 | X40 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
| 3qzh | X69 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
| 4feq | 0T8 | Tyrosine-protein kinase receptor TYRO3 | 2.7.10.1 | 0.454 | |
| 5e92 | ANP | TGF-beta receptor type-2 | 2.7.11.30 | 0.454 | |
| 1gih | 1PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
| 2vwx | 7X4 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.452 | |
| 3pj8 | 404 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
| 3vs3 | VSE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.452 | |
| 4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.452 | |
| 1kbo | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.451 | |
| 2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.451 | |
| 3rk9 | 09Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
| 1ckp | PVB | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
| 1e9h | INR | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
| 1oiy | N41 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
| 2chx | 090 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.450 | |
| 2in6 | 839 | Wee1-like protein kinase | 2.7.10.2 | 0.450 | |
| 3qqk | X02 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
| 4hge | 15V | Tyrosine-protein kinase JAK2 | / | 0.450 | |
| 2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.449 | |
| 3rpr | 25Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
| 2xa4 | AZ5 | Tyrosine-protein kinase JAK2 | / | 0.448 | |
| 4jq8 | KJ8 | Epidermal growth factor receptor | 2.7.10.1 | 0.448 | |
| 4kba | 1QM | Casein kinase I isoform delta | 2.7.11.1 | 0.448 | |
| 2cgw | 3C3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
| 2o0u | C0M | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.447 | |
| 2r64 | 740 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
| 3vt7 | VDX | Vitamin D3 receptor | / | 0.447 | |
| 4kb8 | 1QN | Casein kinase I isoform delta | 2.7.11.1 | 0.447 | |
| 4o0r | X4Z | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.447 | |
| 4qms | 1N1 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.447 | |
| 1ke6 | LS2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
| 2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.446 | |
| 2c4g | 514 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
| 2fb8 | 215 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.446 | |
| 3rm7 | 19Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
| 4gj2 | 0XH | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.446 | |
| 2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.445 | |
| 2vu3 | LZE | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
| 2vwy | 7X5 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.445 | |
| 2w06 | FRV | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
| 2w9s | TOP | Dihydrofolate reductase type 1 from Tn4003 | 1.5.1.3 | 0.445 | |
| 3r28 | XA0 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
| 3sqq | 99Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
| 4e4m | 0NH | Tyrosine-protein kinase JAK2 | / | 0.445 | |
| 1gij | 2PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
| 2cf6 | NAP | Cinnamyl alcohol dehydrogenase 5 | 1.1.1.195 | 0.444 | |
| 2x1n | X1N | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
| 3qwk | X62 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
| 3r73 | X87 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
| 3r9h | Z67 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
| 3ttj | JBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.444 | |
| 4bco | T6Q | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
| 1h1q | 2A6 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
| 1xjd | STU | Protein kinase C theta type | 2.7.11.13 | 0.443 | |
| 1xkk | FMM | Epidermal growth factor receptor | 2.7.10.1 | 0.443 | |
| 2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.443 | |
| 2chz | 093 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.443 | |
| 2pml | ANP | Uncharacterized protein | / | 0.443 | |
| 2vtp | LZ9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
| 3q4z | ANP | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.443 | |
| 3r9d | X6B | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
| 3zh8 | C58 | Protein kinase C iota type | 2.7.11.13 | 0.443 | |
| 4uym | VOR | 14-alpha sterol demethylase Cyp51B | / | 0.443 | |
| 2c47 | 5ID | Casein kinase I isoform gamma-2 | / | 0.442 | |
| 2c6o | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
| 2fvd | LIA | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
| 2vx0 | 7X7 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.442 | |
| 3k5u | PFQ | Aurora kinase A | 2.7.11.1 | 0.442 | |
| 4fx3 | 60K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
| 4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.442 | |
| 4gj3 | 0XP | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.442 | |
| 5hes | 032 | Mitogen-activated protein kinase kinase kinase 20 | 2.7.11.25 | 0.442 | |
| 1oit | HDT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 2i4j | DRJ | Peroxisome proliferator-activated receptor gamma | / | 0.441 | |
| 2wuf | KEM | 4,5:9,10-diseco-3-hydroxy-5,9,17-trioxoandrosta-1(10),2-diene-4-oate hydrolase | 3.7.1.17 | 0.441 | |
| 3rpv | 26Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 4k6z | 1Q3 | Tyrosine-protein kinase JAK1 | / | 0.441 | |
| 3lfn | A27 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
| 3qk0 | QK0 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.440 | |
| 4wkq | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.440 |